These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22990555)
21. Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease. Arai T; Atsukawa M; Tsubota A; Kato K; Abe H; Ono H; Kawano T; Yoshida Y; Tanabe T; Okubo T; Hayama K; Nakagawa-Iwashita A; Itokawa N; Kondo C; Kaneko K; Emoto N; Nagao M; Inagaki K; Fukuda I; Sugihara H; Iwakiri K Sci Rep; 2021 Aug; 11(1):15938. PubMed ID: 34354193 [TBL] [Abstract][Full Text] [Related]
22. Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study. Tarnoki AD; Tarnoki DL; Bata P; Littvay L; Osztovits J; Jermendy G; Karlinger K; Lannert A; Preda I; Kiss RG; Molnar AA; Garami Z; Baffy G; Berczi V Liver Int; 2012 Sep; 32(8):1287-93. PubMed ID: 22651705 [TBL] [Abstract][Full Text] [Related]
23. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. Petit JM; Guiu B; Terriat B; Loffroy R; Robin I; Petit V; Bouillet B; Brindisi MC; Duvillard L; Hillon P; Cercueil JP; Verges B J Clin Endocrinol Metab; 2009 Oct; 94(10):4103-6. PubMed ID: 19584186 [TBL] [Abstract][Full Text] [Related]
24. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Adinolfi LE; Restivo L; Zampino R; Guerrera B; Lonardo A; Ruggiero L; Riello F; Loria P; Florio A Atherosclerosis; 2012 Apr; 221(2):496-502. PubMed ID: 22385985 [TBL] [Abstract][Full Text] [Related]
25. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? Dogru T; Genc H; Tapan S; Ercin CN; Ors F; Aslan F; Kara M; Sertoglu E; Bagci S; Kurt I; Sonmez A Diabetes Res Clin Pract; 2012 Apr; 96(1):47-52. PubMed ID: 22189171 [TBL] [Abstract][Full Text] [Related]
26. Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects. Sato M; Kamada Y; Takeda Y; Kida S; Ohara Y; Fujii H; Akita M; Mizutani K; Yoshida Y; Yamada M; Hougaku H; Takehara T; Miyoshi E Liver Int; 2015 Mar; 35(3):925-35. PubMed ID: 25627311 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. Kucukazman M; Ata N; Yavuz B; Dal K; Sen O; Deveci OS; Agladioglu K; Yeniova AO; Nazligul Y; Ertugrul DT Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):147-51. PubMed ID: 23085576 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Aygun C; Kocaman O; Sahin T; Uraz S; Eminler AT; Celebi A; Senturk O; Hulagu S Dig Dis Sci; 2008 May; 53(5):1352-7. PubMed ID: 17939039 [TBL] [Abstract][Full Text] [Related]
29. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Manco M; Bedogni G; Monti L; Morino G; Natali G; Nobili V Atherosclerosis; 2010 Apr; 209(2):463-8. PubMed ID: 19897197 [TBL] [Abstract][Full Text] [Related]
31. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. Sert A; Pirgon O; Aypar E; Yilmaz H; Odabas D J Pediatr Endocrinol Metab; 2012; 25(9-10):927-34. PubMed ID: 23426822 [TBL] [Abstract][Full Text] [Related]
33. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432 [TBL] [Abstract][Full Text] [Related]